Non-cardiogenic pulmonary edema during basiliximab induction in three adolescent renal transplant patients.

Background: Introduction of the anti-CD-25 mAb basiliximab into renal transplant protocols has reduced the incidence of acute rejection. However, its side-effect profile is still unfolding. We report three adolescents who developed severe non-cardiogenic PE within 2 days of renal transplantation.